Our Brands | GBC Healthcare Innovation & GB Pharma Consumer Solutions

All-in-One Molecular System - GBC AIO M160

English 繁體中文

Science-Driven. Globally Trusted.

GBC (General Biologicals Corporation) delivers a comprehensive healthcare ecosystem that integrates in-vitro diagnostics (IVD), clinical testing services, novel therapeutics, and consumer health products.

oh care® | Bringing Science Into Everyday Wellness

GB Pharma, a wholly owned subsidiary of GBC, manages the oh care® consumer healthcare brand, bringing science-backed innovations into everyday life.
Through P113 antimicrobial peptide (AMP) research and clinical expertise, GB Pharma develops trusted consumer health solutions.

oh care® Product Lines:
• Oral Care: Mouthwash, toothpaste, sprays
• Baby Care: Gentle antimicrobial protection
• Skin Care: Advanced antimicrobial skincare solutions

Clinical Diagnostics & Testing Services

GBC provides comprehensive clinical diagnostic services through its laboratories and global partnerships, supporting hospitals, clinics, CROs, insurance companies, and research institutes:

Danner Laboratory (USA)

Specializing in cytology, pathology, and molecular testing with personalized healthcare solutions.

Danner Laboratory (Canada)

Offers clinical testing services and collaborative technology development.

CurieMed Laboratory (Taiwan)

Nationwide clinical diagnostics integrating multiple clinics and laboratory networks.

COVID-19 Testing

Offering a range of highly accurate yet remarkably affordable COVID-19 tests, GBC is helping to put the pandemic behind us.

Exploring Emerging Trends in Medical Technology: Precision Medicine

GBC co-hosted a seminar on CTC detection, NGS, and integrated healthcare, advancing precision diagnostics.

GBC Launches Voluntary Carbon Inventory | Driving Net-Zero and Sustainable Healthcare

GBC launches a voluntary carbon inventory program to enhance energy efficiency, build green supply chains, and advance sustainable healthcare innovation through stronger ESG practices.

CellBio™ Wins Bronze at Taiwan's National Pharmaceutical Technology & R&D Awards

CellBio™ wins Bronze at Taiwan's National Pharmaceutical Technology & R&D Awards, recognized for its iFiltration™ innovation enabling intact CTC capture and advancing precision oncology.

Understanding COVID-19 Variants From Delta to Kraken: How GBC Diagnostics Stay Ahead

Explore the latest COVID-19 variants, from Delta to Kraken, and see how GBC's GB Rapid Test remains effective against evolving viral mutations.

Staying Accurate Against Omicron: How GBC's Rapid Antigen Test Meets the XBB.1.5 “Kraken” Era

How GBC's N-protein rapid test remains reliable against Omicron/XBB.1.5—and why FDA/CDC-recommended serial testing preserves real-world accuracy.

P113 Antimicrobial Peptide Transforms Oral Care | oh care® Science-Backed Solutions for Family Health

GBC's P113 antimicrobial peptide powers the new oh care® line, delivering clinically proven, alcohol- and fluoride-free oral care solutions for safe, everyday family use.

The Future of Molecular Diagnostics: Driving Precision Medicine Forward

GBC advances molecular diagnostics with real-time PCR and integrated testing platforms, delivering faster, accurate, and accessible solutions to accelerate precision medicine worldwide.

Pathogen Detection Methods: From Rapid Antigen to PCR

Explore how antigen rapid tests and RT-PCR differ, and how GBC integrates both for effective pathogen detection.

AI-Powered Cervical Cancer Screening

GBC integrates thin-layer smears with AI deep learning to automate cervical cancer cell screening, improving accuracy, efficiency, and scalability in digital pathology.

Ct Value Explained: What It Means for COVID-19 Testing

Understand what Ct values mean in qRT-PCR COVID-19 testing, how they're calculated, and their clinical limitations.

RAPID TEST vs. PCR: Understanding COVID-19 Detection Methods

COVID-19 began sweeping across the world starting from late 2019 and the pandemic continues to this day.

Explore More Diagnostic Insights

Vision

To lead the world in integrated diagnostics and healthcare innovation, setting the benchmark for quality, accessibility, and trust.

Mission

To create and deliver state-of-the-art diagnostic and healthcare technologies that transform clinical decisions and improve lives worldwide.